Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Doublle Bioproduct
company
About
Doublle Bioproduct focuses on the research and development of anti-tumor drugs.
- 1 - 10
Highlights
Details
- Last Funding Type
- Private Equity（PE）
- Industries
- Biotechnology,Health Care,Medical,Product Research
- Founded date
- May 28, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Doublle Bioproduct focuses on the research and development of anti-tumor drugs. Doublle Bioproduct has established five new drug research and development functional platforms, including Gene therapy drug industrial production and quality control platform, cell biotherapy research and development and application platform, tumor vaccine and specific immunotherapy product platform, anti-tumor leading macromolecular drug candidate construction, and pharmacodynamics platform.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Doublle Bioproduct has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Sep 25, 2021 from a Private Equity（PE） round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 25, 2021 | Private Equity（PE） | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Doublle Bioproduct is funded by 2 investors.
Kaide Investment
and Guangzhou Nan Yue Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Private Equity（PE） |
|
|
— | Private Equity（PE） |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
